The pharmacology and mechanism of action of riluzole

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Neurology

• Publication date

  1996-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1212/WNL.47.6_Suppl_4.233SPMID 8959995
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Excitotoxicity in ALS

  1996cited by this paper
• Neuroprotective effects of riluzole on a model of Parkinson's disease in the rat.

  1996cited by this paper
• Advances in amyotrophic lateral sclerosis

  1996cited by this paper
• Neuroprotective Strategies in a Model of Chronic Glutamate‐Mediated Motor Neuron Toxicity

  1995cited by this paper
• Methamphetamine and dopamine neurotoxicity: differential effects of agents interfering with glutamatergic transmission.

  1995cited by this paper
• Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity in motoneuron-enriched cultures.

  1995cited by this paper
• Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot study.

  1995cited by this paper
• Excitatory amino acids as a final common pathway for neurologic disorders.

  1994cited by this paper
• Antagonism by riluzole of entry of calcium evoked by NMDA and veratridine in rat cultured granule cells: evidence for a dual mechanism of action

  1994cited by this paper
• Riluzole and experimental parkinsonism: partial antagonism of MPP+-induced increase in striatal extracellular dopamine in rats in vivo

  1994cited by this paper
• Neuroprotective effects of riluzole on N-methyl-D-aspartate- or veratridine-induced neurotoxicity in rat hippocampal slices.

  1994cited by this paper
• Disability care and education in 19th century India: some dates, places and documentation.

  1994cited by this paper
• Differential pharmacology of cloned human and mouse B2 bradykinin receptors.

  1994cited by this paper
• Neuroprotective effects of riluzole in ALS CSF toxicity.

  1994cited by this paper
• Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole.

  1994cited by this paper
• Riluzole and experimental parkinsonism: antagonism of MPTP-induced decrease in central dopamine levels in mice.

  1994cited by this paper
• Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA/kainate receptors.

  1993cited by this paper
• Effect of riluzole on focal cerebral ischemia in rats.

  1993cited by this paper
• The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1.

  1993cited by this paper
• Riluzole prevents anoxic injury in cultured cerebellar granule neurons.

  1993cited by this paper
• Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes.

  1993cited by this paper
• Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo.

  1992cited by this paper
• Neuroprotective actions of riluzole in rodent models of global and focal cerebral ischaemia.

  1992cited by this paper
• Pertussis toxin pretreatment abolishes the inhibitory effect of riluzole and carbachol on D-[3H]aspartate release from cultured cerebellar granule cells.

  1992cited by this paper
• Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre

  1991cited by this paper
• Glutamate Receptors of a Quisqualate‐Kainate Subtype are Involved in the Presynaptic Regulation of Dopamine Release in the Cat Caudate Nucleus in vivo

  1990cited by this paper
• Information management challenges.

  1990cited by this paper
• Is the adipocyte beta-adrenoceptor a prototype for the recently cloned atypical 'beta 3-adrenoceptor'?

  1990cited by this paper
• Is the adipocyte β-adrenoceptor a prototype for the recently cloned atypical ‘β3-adrenoceptor?’

  1990cited by this paper
• Excitatory amino acid neurotoxicity and neurodegenerative disease.

  1990cited by this paper
• Ibotenic acid stimulates D-[3H]aspartate release from cultured cerebellar granule cells.

  1989cited by this paper
• Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils

  1989cited by this paper
• [Pace of demographic transition and age structure change in Korea].

  1989cited by this paper
• 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--II. Biochemical properties.

  1985cited by this paper
• 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--I. Anticonvulsant properties.

  1985cited by this paper
• Effect of H1 blockers alone and in combination with morphine to produce antinociception in mice.

  1985cited by this paper
• Two pharmacological traditions: notes from experience.

  1981cited by this paper
• Excitatory amino acid transmitters.

  1981cited by this paper

• ATH-1105 mitigates multiple pathologies in ALS models both alone and in combination with riluzole

  2026cites this paper
• Glial Cells in Spinal Muscular Atrophy: Speculations on Non-Cell-Autonomous Mechanisms and Therapeutic Implications

  2025cites this paper
• Synthetic strategies towards benzothiazole-based compounds of therapeutic potency: experimental, investigational and approved drugs

  2025cites this paper
• Boldine as a neuroprotective agent against motor neuron degeneration in models of amyotrophic lateral sclerosis

  2025cites this paper
• Novel HOCl-Responsive Theranostic Prodrug for the Early Diagnosis and Therapy of Ischemic Stroke.

  2025cites this paper
• Efficacy of glutamate-GABA modulator riluzole for the treatment of cognitive and psychotic symptoms in 22q11.2 deletion syndrome: A placebo-controlled crossover trial.

  2025cites this paper
• Human TDP-43 overexpression in zebrafish motor neurons triggers MND-like phenotypes through gain-of-function mechanism

  2025cites this paper
• Rational design, docking, simulation, synthesis, and in vitro studies of small benzothiazole molecules as selective BACE1 inhibitors

  2025cites this paper
• Racial and ethnic disparities in ALS: a longitudinal electronic health records study

  2025cites this paper
• Interaction between Riluzole and Human Serum Albumin: A Biophysical Study

  2025cites this paper
• Dysbiosis and Neurodegeneration in ALS: Unraveling the Gut–Brain Axis

  2025cites this paper
• Repurposing riluzole as an anti-osteosarcoma agent

  2025cites this paper
• Genetic Variants in SDC3, KCNA2, KCNK1, KCNK16, and Heat Shock Transcription Factor-1 Genes: An Exploratory Analysis Supporting the Piezo2 Channelopathy Hypothesis in Amyotrophic Lateral Sclerosis Onset

  2025cites this paper
• Conservative and newer drug treatment for degenerative cervical myelopathy

  2025influential citation
• Evaluation of a New Riluzole‐Based Compound VA945 on Sodium and Potassium Conductances Expressed by SH‐SY5Y‐ Derived Neurons

  2025cites this paper
• Effects of riluzole on sevoflurane-induced gasping in adult mice.

  2025cites this paper
• Automated gait analysis indicates efficacy of T-type calcium channel inhibition for mitigation of disrupted calcium signalling in an SCA5 mouse model

  2025cites this paper
• Novel 2-aminothiazole derivatives incorporating 9-alkyl purine moiety: design, synthesis, crystal structure, and bioactivity evaluation

  2025cites this paper
• Levodopa-induced dyskinesia in Parkinson’s disease: an updated review of pharmacological treatments

  2025cites this paper
• Advantages and Disadvantages of Drug Combination Treatment: Riluzole, Metformin and Dexamethasone Effect on Glioblastoma Cell

  2025cites this paper
• Brain white matter damage biomarkers.

  2025cites this paper
• Combining Therapeutic Strategies to Treat the Injured Spinal Cord: A Translational Perspective

  2025cites this paper
• Neuronal nitric oxide synthase (nNOS) uncoupling in ischemic stroke: Mechanisms of oxidative/nitrosative stress and opportunities for neuroprotection: A review.

  2025cites this paper
• Novel Dual Mechanism GRT‑X Agonist Acting on Kv7 Potassium Channel/Translocator Protein Receptor Prevents Motoneuron Degeneration Following Exposure to Mouse and Human Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Astrocyte-Conditioned Media

  2025cites this paper
• Targeting Amyotrophic Lateral Sclerosis with Gene Therapy: From Silencing Genes to Enhancing Neuroprotection

  2025cites this paper
• Neural excitation/inhibition imbalance and neurodevelopmental pathology in human copy number variant syndromes: a systematic review

  2025cites this paper
• Riluzole in Combination with mFOLFOX6 and Bevacizumab in Treating Patients with Metastatic Colorectal Cancer: A Phase 1 Clinical Trial.

  2025cites this paper
• Harnessing Metabolism to Combat Neurodegeneration: Strategies for Reversing Age-Related Cognitive Decline.

  2025cites this paper
• A systematic review and functional in-silico analysis of genes and variants associated with amyotrophic lateral sclerosis

  2025cites this paper
• Skeletal Muscle Biomarkers of Amyotrophic Lateral Sclerosis: A Large‐Scale, Multi‐Cohort Proteomic Study

  2025cites this paper
• Demystifying the Antidepressant Mechanism of Action of Stinels, a Novel Class of Neuroplastogens: Positive Allosteric Modulators of the NMDA Receptor

  2025cites this paper
• Human TDP-43 overexpression in zebrafish motor neurons triggers MND-like phenotypes through gain-of-function mechanism.

  2025cites this paper
• Comparative safety analysis of Riluzole, Edaravone and Tofersen in ALS management: insights from FAERS database

  2025cites this paper
• Safety and Efficacy of Riluzole in Traumatic Spinal Cord Injury: A Systematic Review With Meta-Analyses

  2024cites this paper
• Drug Repurposing and Lysosomal Storage Disorders: A Trick to Treat

  2024cites this paper
• Animal Models of FUS-Proteinopathy: A Systematic Review

  2024cites this paper
• Decoding multiple sclerosis: Unravelling the complexities of pathogenesis, progression, mechanisms and therapeutic innovations.

  2024cites this paper
• Age-dependent dynamics of neuronal VAPBALS inclusions in the adult brain

  2024cites this paper
• Riluzole attenuates acute neural injury and reactive gliosis, hippocampal-dependent cognitive impairments and spontaneous recurrent generalized seizures in a rat model of temporal lobe epilepsy

  2024cites this paper
• The sense of antisense therapies in ALS.

  2024cites this paper
• The pediatric psychopharmacology of autism spectrum disorder: A systematic review part II: The future.

  2024cites this paper
• Late-stage gem-difluoroallylation of phenol in bioactive molecules and peptides with 3,3-difluoroallyl sulfonium salts

  2024cites this paper
• Evaluating emerging drugs in phase II & III for the treatment of amyotrophic lateral sclerosis

  2024cites this paper
• Exploring the Therapeutic Potential of N-Methyl-D-Aspartate Receptor Antagonists in Neuropathic Pain Management

  2024cites this paper
• Copper-Mediated −CF(OCF3)(CF2H) Transfer to Organic Electrophiles

  2024cites this paper
• Riluzole Enhancing anti-PD-1 Efficacy by Activating cGAS/STING Signaling in Colorectal Cancer.

  2024cites this paper
• Novel multitarget directed ligands inspired by riluzole: A serendipitous synthesis of substituted benzo[b][1,4]thiazepines potentially useful as neuroprotective agents.

  2024cites this paper
• A novel KCNC3 gene variant in the voltage-dependent Kv3.3 channel in an atypical form of SCA13 with dominant central vertigo

  2024cites this paper
• The prion-like effect and prion-like protein targeting strategy in amyotrophic lateral sclerosis

  2024cites this paper
• Correlation of surface properties with dissolution behavior of amorphous solid dispersion of riluzole and its pharmacodynamic evaluation.

  2024cites this paper
• Drug repurposing for neurodegenerative diseases.

  2024cites this paper
• Recent Progress of Antisense Oligonucleotide Therapy for Superoxide-Dismutase-1-Mutated Amyotrophic Lateral Sclerosis: Focus on Tofersen

  2024cites this paper
• Hybrid derivatives containing dimethyl fumarate and benzothiazole scaffolds for the potential treatment of multiple sclerosis; in silico & in vivo study

  2024cites this paper
• HDAC6 inhibition as a mechanism to prevent neurodegeneration in the mSOD1G93A mouse model of ALS

  2024cites this paper
• Structural basis for the rescue of hyperexcitable cells by the amyotrophic lateral sclerosis drug Riluzole

  2024cites this paper
• Advancements and challenges in amyotrophic lateral sclerosis

  2024cites this paper
• The role of glial cells in amyotrophic lateral sclerosis.

  2024cites this paper
• The multifaceted functions of β-arrestins and their therapeutic potential in neurodegenerative diseases

  2024cites this paper
• Controlling the Solubility, Release Rate and Permeation of Riluzole with Cyclodextrins

  2024cites this paper
• Riluzole Reverses Blood–Testis Barrier Loss to Rescue Chemotherapy–Induced Male Infertility by Binding to TRPC

  2024cites this paper
• Profiling tofersen as a treatment of superoxide dismutase 1 amyotrophic lateral sclerosis

  2024cites this paper
• Excitotoxicity and ALS: New therapy targets an old mechanism

  2024cites this paper
• Burden of Motor Neuron Diseases in a Tertiary Care Center of Eastern Nepal: A Case Series with Literature Review

  2024cites this paper
• Disulfidptosis-related signature elucidates the prognostic, immunologic, and therapeutic characteristics in ovarian cancer

  2024cites this paper
• Molecular and cellular mechanisms of selective vulnerability in neurodegenerative diseases

  2024cites this paper
• [Promising approaches to the pathogenetic therapy of amyotrophic lateral sclerosis].

  2024cites this paper
• Asymmetric Mannich/Cyclization Reaction of 2-Benzothiazolimines and 2-Isothiocyano-1-indanones to Construct Chiral Spirocyclic Compounds

  2024cites this paper
• Synthesis and Evaluation of NH2 and SH Linker Free Benzothiazole-Triazole Compounds: Insights into Antimicrobial Efficacy

  2024cites this paper
• Current insights into the management of spinal cord injury.

  2023cites this paper
• Accelerate the diagnosis of amyotrophic lateral sclerosis using the Gold Coast criteria and biomarkers

  2023cites this paper
• Pharmacotherapy: Ketamine and Esketamine.

  2023cites this paper
• Small molecules targeting different cellular pathologies for the treatment of amyotrophic lateral sclerosis

  2023cites this paper
• A Glutamate Scavenging Protocol Combined with Deanna Protocol in SOD1-G93A Mouse Model of ALS

  2023cites this paper
• Riluzole treatment modulates KCC2 and EAAT-2 receptor expression and Ca2+ accumulation following ventral root avulsion injury.

  2023cites this paper
• Unsupervised machine learning identifies distinct molecular and phenotypic ALS subtypes in post-mortem motor cortex and blood expression data

  2023cites this paper
• Proteostasis and Ribostasis Impairment as Common Cell Death Mechanisms in Neurodegenerative Diseases

  2023cites this paper
• Sodium Phenylbutyrate and Taurursodiol: A New Therapeutic Option for the Treatment of Amyotrophic Lateral Sclerosis

  2023cites this paper
• Unsupervised machine learning identifies distinct ALS molecular subtypes in post-mortem motor cortex and blood expression data

  2023cites this paper
• The role of glutamate receptors in the regulation of the tumor microenvironment

  2023cites this paper
• Masitinib: The promising actor in the next season of the Amyotrophic Lateral Sclerosis treatment series.

  2023cites this paper
• Canonical and Non-Canonical Antipsychotics’ Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia

  2023cites this paper
• Riluzole in Spinal Cord Injury Study (RISCIS)–Pharmacokinetic (PK) Sub-Study: An Analysis of Pharmacokinetics, Pharmacodynamics, and Impact on Axonal Degradation of Riluzole in Patients With Traumatic Cervical Spinal Cord Injury Enrolled in the RISCIS Phase III Randomized Controlled Trial

  2023cites this paper
• Development and Evaluation of Amorphous Solid Dispersion of Riluzole with PBPK Model to Simulate the Pharmacokinetic Profile

  2023cites this paper
• Photocatalytic Three-Component Reaction for the Synthesis of Multifunctional Diaryl Sulfides.

  2023cites this paper
• 2(3H)-Dihydrofranolactone metabolites from Pleosporales sp. NUH322 as anti-amyotrophic lateral sclerosis drugs

  2023cites this paper
• N-Succinylaspartic-Acid-Conjugated Riluzole Is a Safe and Potent Colon-Targeted Prodrug of Riluzole against DNBS-Induced Rat Colitis

  2023cites this paper
• Exploring Advancements in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review of Current Modalities and Future Prospects

  2023cites this paper
• Blood-spinal cord barrier disruption in degenerative cervical myelopathy

  2023cites this paper
• Neuroprotective effects of riluzole in Alzheimer's disease: A comprehensive review

  2023cites this paper
• Aberrant axon initial segment plasticity and intrinsic excitability of ALS hiPSC motor neurons

  2023cites this paper
• Therapeutic Effects of Combination of Nebivolol and Donepezil: Targeting Multifactorial Mechanisms in ALS

  2023cites this paper
• Ketamine: Mechanisms and Relevance to Treatment of Depression.

  2023cites this paper
• Why should we care about astrocytes in a motor neuron disease?

  2023cites this paper
• Janus kinase inhibitors are potential therapeutics for amyotrophic lateral sclerosis

  2023cites this paper
• An In Vivo Electroencephalographic Analysis of the Effect of Riluzole against Limbic and Absence Seizure and Comparison with Glutamate Antagonists

  2023cites this paper
• Microglial crosstalk with astrocytes and immune cells in amyotrophic lateral sclerosis

  2023cites this paper
• Effects of riluzole on psychiatric disorders with anxiety or fear as primary symptoms: A systematic review

  2023cites this paper
• Role of NaV1.6-mediated persistent sodium current and bursting-pacemaker properties in breathing rhythm generation

  2023cites this paper
• Do long‐lasting effects of epidural polarization of afferent fibres depend on persistent sodium current?

  2023cites this paper
• Riluzole, a Derivative of Benzothiazole as a Potential Anti-Amoebic Agent against Entamoeba histolytica

  2023cites this paper